Меню
Идёт набор NCT06667739

Promoting Physical Activity Following Dysvascular Amputation

Без фазы С лечением Amputation Lower Limb Amputation Knee

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: IMPACT-L3.
Кому может быть актуально
Состояния в реестре: Amputation, Lower Limb Amputation Knee. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Канада
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

A Behaviour Change Intervention Promoting Physical Activity Following Dysvascular Amputation: a Pilot Study

Обзор

Loss of a lower limb due to diabetes can have a devastating impact on physical and mental health and quality of life. Individuals are at risk of other diseases such as cardiovascular disease, loss of the other limb and death. Physical activity can reduce risk of chronic disease and improve health outcomes; however, physical activity levels in people with limb loss are low, often due to reduced balance and walking ability. Rehabilitation services are not readily available and the cost of delivering such programs remains high. Working with individuals with lower limb amputation, we created a virtual, peer-led physical activity behaviour change intervention called IMproving Physical Activity through Coaching and Technology following Lower Limb Loss (IMPACT-L3). We will conduct a pilot study to assess feasibility and optimize design of a future trial of effectiveness.

Подробное описание

Background and Importance: Diabetes-related lower limb amputation (LLA) is a leading cause of disability globally, impacting individuals' physical and mental health and ultimately their quality of life. Individuals with LLA due to diabetes or other vascular disease (dysvascular LLA) often have comorbidities, including higher rates of cardiovascular disease than the general population. They are at risk of amputation in the contralateral limb and have high mortality rates (30% at one year).

There is strong evidence demonstrating that physical activity reduces risk of chronic disease and mortality and improves quality of life. However, people with dysvascular LLA often have reduced strength, balance, walking ability and increased energy expenditure during ambulation. Consequently, they have impaired mobility that can lead to sedentary behaviour. Across studies examining physical activity in people with dysvascular LLA, step counts ranged from 1250 steps/day in older prosthesis users to 3809±2189 steps/day in people with diabetes-related LLA. Unfortunately, limited availability of rehabilitation services for people with LLA and the high cost of delivering healthcare interventions makes provision of support for physical activity challenging. To address this gap, we co-created a physical activity intervention, IMproving Physical Activity through Coaching and Technology following Lower Limb Loss (IMPACT-L3), to support physical activity behaviour change in people with dysvascular LLA. Prior to launching a large trial, a pilot study is required to assess feasibility and optimize design of a future trial. This study aims to assess the feasibility of conducting a definitive randomized controlled trial (RCT) to determine the effectiveness of a virtual peer-led physical activity intervention on levels of physical activity and self-efficacy in people with dysvascular LLA. Specific objectives are to: 1) evaluate feasibility according to indicators of process, resources, management and treatment; 2) explore perceptions of program characteristics, program implementation and study procedures among individuals with LLA; 3) explore the perceived feasibility and acceptability of the program among peer coaches; and 4) inform a sample size calculation for a future trial of effectiveness.

Methods: This pilot study is a parallel group RCT with an embedded qualitative component. The intervention group will have access to once-weekly virtual peer coaching sessions with a gender and level of amputation-matched peer trained in brief action planning; web-based physical activity modules; and a wearable activity monitor for 8 weeks. The control group will continue their usual health care and be offered the intervention at the end of the follow-up period. Data on feasibility of implementing the intervention and conducting the trial will be collected including assessment of process, resource, management and treatment indicators. Progression Criteria: A traffic light approach (red, amber, green) will be used to guide the research team in determining what changes may be required to address identified challenges based on the indicators and in determining the feasibility of progression to a trial. The proposed primary outcomes for a future trial will be measured at baseline, post intervention (week 9) and 4 week follow-up: total physical activity counts per day measured by the ActiGraphTM activity monitor and self-efficacy measured by the Self-efficacy for Exercise scale. Other outcome measures include: the Physical Activity Scale for Individuals with Physical Disability, Frenchay Activity Index, the Center for Epidemiologic Studies Depression Scale, Activities-specific Balance Confidence scale, Prosthesis Evaluation Questionnaire - Mobility Section, and Short Form Health Survey 12 Item survey. Semi-structured interviews will explore feasibility and acceptability of the intervention to participants (\~15-20 participants) and peers. Inductive thematic analysis will be employed to analyze qualitative interviews.

Вмешательства

  • Поведенческое IMPACT-L3
    The intervention is a physical activity behaviour change intervention: IMproving Physical Activity through Coaching and Technology following Lower Limb Loss (IMPACT-L3). Two theories provide a framework for IMPACT-L3. One is social cognitive theory and the other is self-determination theory. As mHealth solutions have the potential to increase access and improve health outcomes, IMPACT-L3 will be delivered entirely virtually.

Первичные конечные точки

  • Consent rate: the percent of recruited individuals who provide consent per month. [Срок оценки: 8 weeks]
  • Withdrawal Rate: the percent of study participants withdrawing by 9 weeks and 4 week follow-up [Срок оценки: enrollment to 13 weeks]
  • Peer coach adherence: total number of peer coaching sessions attended by the peer-trainer. [Срок оценки: enrollment to 8 weeks]
  • Participant and tester burden: the amount of time it took to administer study outcomes at T1, T2, and T3 and the acceptability of the evaluation time commitment from the perspective of participants. [Срок оценки: Baseline, end of intervention (week 9) and 4 week follow-up]
  • Feasibility of data collection: percentage of participants with complete data on each measure at each evaluation time point. [Срок оценки: Baseline, end of intervention (week 9) and 4 week follow-up]
  • Participant processing time: time from initial contact to enrollment. [Срок оценки: 8 weeks]
  • Intervention fidelity: study-specific checklist outlining key components of the intervention completed by peers. [Срок оценки: enrollment to 8 weeks]
  • Adverse events: the number of adverse events that occurred during physical activity for the intervention. [Срок оценки: enrollment to 8 weeks]
  • Usage of web-based module: number of completed modules and number of logins. [Срок оценки: enrollment to 8 weeks]
  • Participant recruitment rate: the number and proportion of participants recruited per month [Срок оценки: 8 weeks]
Вторичные конечные точки (11)
  • Objective physical activity [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Self-efficacy for Exercise Scale [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Self-Regulatory Efficacy for Exercise [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Center for Epidemiologic Studies Depression Scale (CES-D) [Срок оценки: Baseline, week 9, 4 week follow-up]
  • The Physical Activity Scale for Individuals with Physical Disability (PASIPD) [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Leisure-Time Physical Activity for People with Disabilities Questionnaire (LTPAQ-D) [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Activities-specific Balance Confidence scale (ABC) [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Prosthesis Evaluation Questionnaire - Mobility Section (PEQ-MS) [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Short Form Health Survey 12 Item survey (SF-12) [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Frenchay Activities Index (FAI) [Срок оценки: Baseline, week 9, 4 week follow-up]
  • Self Efficacy for Exercise: Dysvascular Lower Limb Amputees [Срок оценки: Baseline, week 9, 4 week follow-up]

Критерии участия

Критерии включения

  • Dysvascular LLA (LLA due to diabetes or vascular disease)
  • major LLA (at the ankle or above)
  • living in the community
  • adult at least 18 years of age
  • comfortable communicating in English and able to understand basic English
  • receptive to using a phone or tablet (e.g., to enable peer coaching, access to modules.

Критерии исключения

  • actively receiving rehabilitation services related to physical activity/mobility
  • recommended medical supervision for physical activity by health care provider, or skin problems preventing usual activity
  • not able to provide informed consent.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Поддерживающая терапия

Центры проведения

Канада · 1 центр
  • West Park Healthcare Centre — Toronto

Идентификаторы

NCT: NCT06667739 · 24-001-WP

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗